1-4 of 4
Gerry Oster, PhD
Close
Sort by
Journal Articles

Cost-Effectiveness Of Lenalidomide and Bortezomib In Patients With Previously Untreated Multiple Myeloma (MM)

Gerry Oster, PhD, Ariel Berger, MPH, Rebecca Bornheimer, BA, Gary Binder, MBA, Yasir Nagarwala, MD
Journal: Blood
Blood (2013) 122 (21): 5604.
https://doi.org/10.1182/blood.V122.21.5604.5604
Published: 2013
Journal Articles

Oral Mucositis (OM) and Outcomes of Autologous (AU) Hematopoietic Stem Cell Transplantation (HSCT) Following High-Dose Melphalan (MP) Conditioning for Multiple Myeloma (MM).

Gerry Oster, PhD, Montserrat Vera-Llonch, MD, M.P.H., Colleen Ford, John Lu, MD, Irina Khazanov, Stephen Sonis, DMD, DMSc
Journal: Blood
Blood (2005) 106 (11): 1343.
https://doi.org/10.1182/blood.V106.11.1343.1343
Published: 2005
Journal Articles

Oral Mucositis (OM) and Outcomes of Allogeneic (AL) Hematopoietic Stem Cell Transplantation (HSCT) in Patients with Hematologic Malignancies.

Montserrat Vera-Llonch, MD, MPH, Gerry Oster, PhD, Colleen Ford, John Lu, PhD, Irina Khazanov, Stephen Sonis, DMD, DMSc
Journal: Blood
Blood (2005) 106 (11): 3126.
https://doi.org/10.1182/blood.V106.11.3126.3126
Published: 2005
Journal Articles

Cost of Major Bleeding Following Major Orthopedic Surgery.

Gerry Oster, PhD, Montserrat Vera-Llonch, MD, MPH, May Hagiwara, PhD
Journal: Blood
Blood (2004) 104 (11): 4061.
https://doi.org/10.1182/blood.V104.11.4061.4061
Published: 2004